跳至主要内容
临床试验/NCT01326520
NCT01326520已完成不适用

Effect of Dietary Milk Phospholipids on Subjects With Atopic Dermatitis

University of Jena2 个研究点 分布在 1 个国家目标入组 39 人开始时间: 2011年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
39
试验地点
2
主要终点
Change in skin texture from baseline and in comparison with placebo

研究概览

简要总结

The aim of the study is to investigate the influence of a milk phospholipid enriched dairy product on subjects with atopic dermatitis determining parameters of the immune status, the plasma lipid profile and the skin texture.

详细描述

Based on the facts, that on the one hand milk phospholipids are characterized by a high sphingolipid content and on the other hand a disturbed sphingolipid metabolism in the epidermis of patients with atopic dermatitis was verified, a double blinded, controlled, randomized, cross-over study with a daily supplementation of 3 g milk phospholipids to subjects with a mild to moderate atopic dermatitis will be conducted.

Forty patients will be randomized between two groups of each 20 patients. After an individual checkup and a run-in period of 2 weeks, the one group will receive the phospholipid enriched dairy product and the second group will be given a placebo dairy product over two month. A wash out-period of 4 weeks will follow, and the patients will consume the contrary dairy products over two month after a 2-week run-in period again.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • mild to moderate atopic dermatitis (SCORAD < 30)
  • age: 18 - 60 years

排除标准

  • intolerance against milk proteins
  • systemic medication with corticosteroids or antihistamines
  • immune mediated disease
  • atherosclerosis
  • hyperlipidaemia
  • diabetes mellitus
  • angina pectoris
  • adipositas
  • pregnancy and breast feeding

结局指标

主要结局

Change in skin texture from baseline and in comparison with placebo

时间窗: after 0,2,10,16, and 24 weeks

SCORAD Index

次要结局

  • Immune status(after 0,2,10,16, and 24 weeks)
  • Lipid status(after 0,2,10,16, and 24 weeks)

研究者

发起方
University of Jena
申办方类型
Other
责任方
Principal Investigator
主要研究者

Gerhard Jahreis

Prof. Dr.

University of Jena

研究点 (2)

Loading locations...

相似试验